MedTrace Logo

The Effectiveness of an Exergame-based Intervention

NCT05712317 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 43

Last updated 2026-05-13

No results posted yet for this study

Summary

This randomized control trial aims to compare the effects of a regular exergame-based intervention and a regular moderate-intensity endurance exercise in healthy individuals. The main questions it aims to answer are:

• Is regular exergame-based training an effective intervention to improve different health and performance parameters in healthy adults? Can the exergaming intervention improve health and performance parameters similar to a moderate-intensity endurance exercise intervention? Throughout the intervention period (8 weeks), participants will participate in regular training sessions (3x/week) in an exergame called the ExerCube.

Researchers will compare the effects to a control group who participates in regular (3x/week) moderate-intensity endurance exercise to see if the exergaming intervention induces similar effects on health and performance parameters.

Conditions

  • Blood Pressure
  • Physical Inactivity

Interventions

BEHAVIORAL

Exergame Intervention

8-week exergame-based intervention 3x per week

BEHAVIORAL

Moderate-intensity endurance exercise

8-week moderate-intensity endurance exercise 3x per week

Sponsors & Collaborators

  • University of Bern

    lead OTHER

Principal Investigators

  • Sascha Ketelhut, Dr. · University of Bern

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-01
Primary Completion
2025-01-01
Completion
2025-02-01

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05712317 on ClinicalTrials.gov